Andrea van Puffelen
The knowledge we gather with WGS can bring us a step closer to our goal to find an effective and suitable treatment for every single patient, not based on ‘one size fits all’, but adjusted to the characteristics of the patient and the tumor.
Back to newsMore news
In search of the optimal treatment strategy for glioblastoma
Patients with recurrent glioblastoma have an unfavorable outlook and few treatment options. The recently launched GLOW study should change this …
In the media: Genomeweb: Partial reimbursement for comprehensive DNA test in the Netherlands
This week, Genomeweb’s Precision Oncology News brought the news that the Dutch House of Representatives has recently unanimously decided to …
New cancer treatment options created by full DNA-analysis
Nature publication reports study by Netherlands Center for Personalized Cancer Treatment showing benefits for targeted treatments outside registered indications 2 …
We have been using the complete DNA test for the past two years in the routine care of patients with cancer. The test provides at least as much, and often more, information we can use to treat our patients than regular tests. Moreover, in patients with an unknown primary tumor, it can help us to diagnose the cancer and find a treatment. This test also makes a difference for patients with a sarcoma. Our researchers have scientifically demonstrated this in several studies.